Show simple item record

dc.contributor.authorGalley, Helen
dc.contributor.authorAllen, L.
dc.contributor.authorCollin, P.J.
dc.contributor.authorGalt , SP
dc.contributor.authorWebster, NR
dc.date.accessioned2022-09-12T14:51:01Z
dc.date.available2022-09-12T14:51:01Z
dc.date.issued2022-11-01
dc.identifier.citationGalley , H , Allen , L , Collin , P J , Galt , SP & Webster , NR 2022 , ' Dose assessment of melatonin in sepsis (DAMSEL2) study : Pharmacokinetics of two doses of oral melatonin in patients with sepsis ' , Journal of Pineal Research , vol. 73 , no. 4 , 12830 . https://doi.org/10.1111/jpi.12830en
dc.identifier.issn0742-3098
dc.identifier.otherPURE: 218856519
dc.identifier.otherPURE UUID: 1d8ce188-105a-41fa-98c1-5d57917958ea
dc.identifier.otherPubMed: 36046952
dc.identifier.otherWOS: 000853119000001
dc.identifier.otherScopus: 85137828111
dc.identifier.urihttps://hdl.handle.net/2164/19162
dc.descriptionOpen Access via the Wiley OA Agreement Funding The work was funded by the Scottish Government under the Experimental and Translational Medicine funding scheme of the Chief Scientist Office of Scotland, UK, reference number ETM/538 Funding Information: Written informed consent was obtained either from the patient, or, since most of the patients were not able to consent for themselves, their legal representative—a welfare guardian, a welfare attorney, a near relative or close friend, a clinical person not involved in the study, or another independent person nominated by the healthcare provider, according to the Medicines for Human Use (Clinical Trial) Regulations 2004. Trial Steering and Data and Safety Monitoring Committees with external chairs were established. The study was sponsored jointly by the University of Aberdeen and NHS Grampian and was monitored by NHS Grampian. The work was funded by the Chief Scientist Office of Scotland (Reference number ETM/538). Funding Information: The work was funded by the Scottish Government under the Experimental and Translational Medicine funding scheme of the Chief Scientist Office of Scotland, UK, reference number ETM/538. Publisher Copyright: © 2022 The Authors. Journal of Pineal Research published by John Wiley & Sons Ltd.en
dc.format.extent12
dc.language.isoeng
dc.relation.ispartofJournal of Pineal Researchen
dc.rightsThis is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. © 2022 The Authors. Journal of Pineal Research published by John Wiley & Sons Ltd.en
dc.subjectmelatoninen
dc.subjectsepsisen
dc.subjectpharmacokineticsen
dc.subjectclinical trialen
dc.subjectR Medicineen
dc.subjectChief Scientist Office (CSO)en
dc.subjectETM/538en
dc.subject.lccRen
dc.titleDose assessment of melatonin in sepsis (DAMSEL2) study : Pharmacokinetics of two doses of oral melatonin in patients with sepsisen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.contributor.institutionUniversity of Aberdeen.Medical Educationen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1111/jpi.12830


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record